Dihydrotanshinone I as a novel signal transducer and activator of transcription 3 inhibitor for glioblastoma treatment.

Saved in:
Bibliographic Details
Title: Dihydrotanshinone I as a novel signal transducer and activator of transcription 3 inhibitor for glioblastoma treatment.
Authors: Cheng KW; Department of Medical Research Center, Shaoxing People's Hospital, School of Medicine, ShaoXing University, Shaoxing, 312000, China.; Department of Neurology, Shaoxing People's Hospital, Shaoxing, 312000, China., Zhou SJ; Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, 310058, China., Zeng J; Department of Neurology, Shaoxing People's Hospital, Shaoxing, 312000, China.; School of Medicine, ShaoXing University, Shaoxing, 312000, China., Zhang YR; Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, 310058, China., Jin BQ; School of Medicine, ShaoXing University, Shaoxing, 312000, China., Wang P; Department of Blood Transfusion, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, 312000, China., He LY; Department of Traditional Chinese Medicine, Shaoxing People's Hospital, Zhejiang University Shaoxing Hospital, Shaoxing, China., Qi XC; Department of Neurosurgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310024, China., Liu XD; Bioengineering College of Chongqing University, Chongqing, 400030, China. liuxubio@126.com., Yu LS; Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. yuls@zju.edu.cn.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, 310058, China. yuls@zju.edu.cn., Zhang YX; Department of Neurology, Shaoxing People's Hospital, Shaoxing, 312000, China. auwxf01@163.com.; School of Medicine, ShaoXing University, Shaoxing, 312000, China. auwxf01@163.com.; State Key Laboratory of Neurology and Oncology Drug Development, Jiangsu Simcere Pharmaceutical Co. Ltd., 699-18 Xuan Wi Avemue, Nanjing, Jiangsu, 210042, China. auwxf01@163.com.
Source: Journal of translational medicine [J Transl Med] 2026 Jun 11. Date of Electronic Publication: 2026 Jun 11.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42277880
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dihydrotanshinone I as a novel signal transducer and activator of transcription 3 inhibitor for glioblastoma treatment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cheng+KW%22">Cheng KW</searchLink>; Department of Medical Research Center, Shaoxing People's Hospital, School of Medicine, ShaoXing University, Shaoxing, 312000, China.; Department of Neurology, Shaoxing People's Hospital, Shaoxing, 312000, China.<br /><searchLink fieldCode="AU" term="%22Zhou+SJ%22">Zhou SJ</searchLink>; Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, 310058, China.<br /><searchLink fieldCode="AU" term="%22Zeng+J%22">Zeng J</searchLink>; Department of Neurology, Shaoxing People's Hospital, Shaoxing, 312000, China.; School of Medicine, ShaoXing University, Shaoxing, 312000, China.<br /><searchLink fieldCode="AU" term="%22Zhang+YR%22">Zhang YR</searchLink>; Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, 310058, China.<br /><searchLink fieldCode="AU" term="%22Jin+BQ%22">Jin BQ</searchLink>; School of Medicine, ShaoXing University, Shaoxing, 312000, China.<br /><searchLink fieldCode="AU" term="%22Wang+P%22">Wang P</searchLink>; Department of Blood Transfusion, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, 312000, China.<br /><searchLink fieldCode="AU" term="%22He+LY%22">He LY</searchLink>; Department of Traditional Chinese Medicine, Shaoxing People's Hospital, Zhejiang University Shaoxing Hospital, Shaoxing, China.<br /><searchLink fieldCode="AU" term="%22Qi+XC%22">Qi XC</searchLink>; Department of Neurosurgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310024, China.<br /><searchLink fieldCode="AU" term="%22Liu+XD%22">Liu XD</searchLink>; Bioengineering College of Chongqing University, Chongqing, 400030, China. liuxubio@126.com.<br /><searchLink fieldCode="AU" term="%22Yu+LS%22">Yu LS</searchLink>; Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. yuls@zju.edu.cn.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, 310058, China. yuls@zju.edu.cn.<br /><searchLink fieldCode="AU" term="%22Zhang+YX%22">Zhang YX</searchLink>; Department of Neurology, Shaoxing People's Hospital, Shaoxing, 312000, China. auwxf01@163.com.; School of Medicine, ShaoXing University, Shaoxing, 312000, China. auwxf01@163.com.; State Key Laboratory of Neurology and Oncology Drug Development, Jiangsu Simcere Pharmaceutical Co. Ltd., 699-18 Xuan Wi Avemue, Nanjing, Jiangsu, 210042, China. auwxf01@163.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101190741%22">Journal of translational medicine</searchLink> [J Transl Med] 2026 Jun 11. <i>Date of Electronic Publication: </i>2026 Jun 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101190741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1479-5876 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214795876%22">14795876 </searchLink><i>NLM ISO Abbreviation: </i>J Transl Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42277880
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12967-026-08385-7
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Dihydrotanshinone I as a novel signal transducer and activator of transcription 3 inhibitor for glioblastoma treatment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cheng KW
      – PersonEntity:
          Name:
            NameFull: Zhou SJ
      – PersonEntity:
          Name:
            NameFull: Zeng J
      – PersonEntity:
          Name:
            NameFull: Zhang YR
      – PersonEntity:
          Name:
            NameFull: Jin BQ
      – PersonEntity:
          Name:
            NameFull: Wang P
      – PersonEntity:
          Name:
            NameFull: He LY
      – PersonEntity:
          Name:
            NameFull: Qi XC
      – PersonEntity:
          Name:
            NameFull: Liu XD
      – PersonEntity:
          Name:
            NameFull: Yu LS
      – PersonEntity:
          Name:
            NameFull: Zhang YX
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 06
              Text: 2026 Jun 11
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1479-5876
          Titles:
            – TitleFull: Journal of translational medicine
              Type: main
ResultId 1